SecBot SecBot
SECBOTREPLAY Home › Report › OTLK

OTLK · Outlook Therapeutics is issuing 8,539,709 shares of common stock at…

Outlook Therapeutics, Inc. · 424B5 filed May 29, 2026 at 08:30 ET

At the news

BEARISHIMPACT 7/10

424B5 filed May 29, 2026 at 08:30 ET

Outlook Therapeutics is issuing 8,539,709 shares of common stock at $0.5855 per share to a single accredited investor, raising approximately $4.9 million in net proceeds. Concurrently, the company is amending outstanding warrants for 15,488,570 shares, reducing their exercise price from $1.78 to $0.5855 per share. The company has substantial doubt about its ability to continue as a going concern, with cash and equivalents of $7.7 million as of March 31, 2026, and expects combined funds to only sustain operations into September 2026.

  • Offering 8,539,709 shares at $0.5855/share for ~$4.9M net proceeds
  • Amending 15,488,570 warrants from $1.78 to $0.5855 exercise price
  • Cash and equivalents of $7.7M as of March 31, 2026
  • Combined funds with April 2026 offering ($4.5M) expected to fund operations only into September 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access